Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · IEX Real-Time Price · USD

73.43

-0.78 (-1.05%)

At close: May 31, 2024, 4:00 PM

73.50

+0.07 (0.10%)

After-hours: May 31, 2024, 6:23 PM EDT

Axsome Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Revenue	270.6	50.04	0	0	0	Upgrade
Revenue Growth (YoY)	440.80%	-	-	-	-	Upgrade
Cost of Revenue	26.07	5.2	0	0	0	Upgrade
Gross Profit	244.54	44.84	0	0	0	Upgrade
Selling, General & Admin	323.12	159.25	66.65	28.9	13.6	Upgrade
Research & Development	97.94	57.95	58.06	70.24	53.65	Upgrade
Other Operating Expenses	55.29	7.44	0	0	0	Upgrade
Operating Expenses	476.36	224.64	124.71	99.14	67.25	Upgrade
Operating Income	-231.83	-179.8	-124.71	-99.14	-67.25	Upgrade
Interest Expense / Income	6.45	7.34	5.7	2.57	1.24	Upgrade
Other Expense / Income	-	-	-	1.25	-	Upgrade
Pretax Income	-238.28	-187.13	-130.4	-102.95	-68.48	Upgrade
Income Tax	0.96	0	0	-0.05	-0.14	Upgrade
Net Income	-239.24	-187.13	-130.4	-102.9	-68.35	Upgrade
Shares Outstanding (Basic)	45	41	38	37	34	Upgrade
Shares Outstanding (Diluted)	45	41	38	37	34	Upgrade
Shares Change	11.73%	8.07%	1.11%	9.37%	26.55%	Upgrade
EPS (Basic)	-5.27	-4.60	-3.47	-2.77	-2.01	Upgrade
EPS (Diluted)	-5.27	-4.60	-3.47	-2.77	-2.01	Upgrade
Free Cash Flow	-145.66	-117.21	-108.53	-78.5	-46.39	Upgrade
Free Cash Flow Per Share	-3.21	-2.88	-2.88	-2.11	-1.36	Upgrade
Gross Margin	90.37%	89.61%	-	-	-	Upgrade
Operating Margin	-85.67%	-359.33%	-	-	-	Upgrade
Profit Margin	-88.41%	-373.99%	-	-	-	Upgrade
Free Cash Flow Margin	-53.83%	-234.25%	-	-	-	Upgrade
EBITDA	-223.54	-174.24	-123.55	-100.31	-67.21	Upgrade
EBITDA Margin	-82.61%	-348.21%	-	-	-	Upgrade
Depreciation & Amortization	8.28	5.56	1.16	0.08	0.04	Upgrade
EBIT	-231.83	-179.8	-124.71	-100.39	-67.25	Upgrade
EBIT Margin	-85.67%	-359.33%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).